A recent study performed cfDNA analysis of plasma and pleural effusion in patients with KLA and identified somatic activation mutations in NRAS in approximately 30% of endothelial cells from isolated LECs from GLA patients, which further demonstrated the possibility of somatic NRAS mutations causing GLA (63). The gene discussed is NRAS; the disease is Pleural effusion.